Qing Chen, MD, PhD

thumbnail_Scientist Headshot Icon

Associate Professor

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Educational Background

  • 08/2000-06/2006 Ph.D, Immunology, Roswell Park Cancer Institute, State University of New York at Buffalo, Buffalo, NY, USA. Thesis advisor: Dr. Sharon S. Evans. Thesis title: ‘Role of proinflammatory cytokines in controlling lymphocyte trafficking during fever-range thermal stress’. 
  • 09/1997-07/2000 M.S., Molecular Neurobiology, Beijing Institute of Neuroscience, Capital University of Medical Sciences, Beijing, China. Thesis advisor: Dr. QunYuan Xu. Thesis focus: ‘Pathological changes in Parkinson’s disease’. 
  • 09/1992—07/1997 M.D., Clinical Medicine, Capital University of Medical Sciences, Beijing, China

Memberships

  • 2003- American Association for Cancer Research (AACR)

Honors & Awards

  • 2004-2006 Predoctoral Traineeship, U.S. Department of Defense, Breast Cancer Research Program (W81XWH-04-1-0354)
  • 2004 Dissertation Research Award, Susan Komen Breast Cancer Foundation (declined because of overlap with DoD predoctoral traineeship)
  • 2006 Dean’s Award for outstanding dissertation, Roswell Park Cancer Institute, State University of New York at Buffalo
  • 2009-2012 HHMI sponsored Postdoctoral fellowship, Life Science Research Foundation
  • 2014 Scholar- in-Training Award, AACR Conference ‘New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures’
  • 2015-2018 The NCI Transition Career Development Award (K22CA181470-01)
  • 2017-2020 Susan G. Komen Career Catalyst Award
  • 2018-2019 The Jayne Koskinas Ted Giovanis Foundation for Health and Policy Award
  • 2018-2020 V Foundation Award
  • 2019 Legacy of Hope Merit Award
  • 2023 Tara Miller Melanoma Foundation Team Science Grant
  • 2023 Melanoma Research Program, U.S. Department of Defense, Idea Award

Research Interests

My lab employs multi-disciplinary approaches to understand the interactions between metastatic cancer cells and the brain stromal cells. We have been focusing on astrocytes, the most abundant brain stromal cells. We have found that astrocytes support the metastatic outgrowth. Moreover, the dynamic interactions between cancer cells and astrocytes create a unique immune microenvironment in the brain metastatic lesions. Our studies are exposing novel mechanisms which can provide potential therapeutic targets to control brain metastases

Selected Publications

1. Chen Q, Wang WC, Evans SS. Tumor microvasculature as a barrier to anti-tumor immunity. Cancer Immunol Immunother. 52:670, 2003.

2. Appenheimer MM, Chen Q, Girard RA, Wang WC, Evans SS. Impact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte trafficking. Immunol Invest. 34:295, 2005. CURRICULUM VITAE Qing Chen

3. Chen Q, Evans SS. Thermal regulation of lymphocyte trafficking: hot spots of the immune response. Int J Hyperthermia. 21:723, 2005.

4. Chen Q, Fisher DT, Kucinska SA, Wang WC, Evans SS. Dynamic control of lymphocyte trafficking by fever-range thermal stress. Cancer Immunol Immunother. 55:299, 2006.

5. Fisher DT, Chen Q, Appenheimer MM, Skitzki J, Wang WC, Odunsi K, Evans SS. Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol Invest. 35:251. 2006 [Shared first-author].

6. Vardam TD, Zhou L, Appenheimer MM, Chen Q, Wang WC, Baumann H, Evans SS. Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance. Cytokine. 39:84, 2007

7. Chen Q, Clancy KA, Wang WC, Evans SS. High endothelial venules: master regulators of lymphocyte trafficking and targets of fever-range thermal stress. In: Endothelial Biomedicine; William Aird, editor; Cambridge University Press. 2007

8. Evans SS, Fisher DT, Skitzki JJ, Chen Q Targeted regulation of a lymphocyte-endothelialinterleukin-6 axis by thermal stress. Int J Hyperthermia. 24:67, 2008

9. Chen Q, Massagué J. Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. Clin Cancer Res. 18:5520, 2012

10. Eroglu Z, Holmen SL, Chen Q, Khushalani NI, Amaravadi R, Thomas R, Ahmed KA, Tawbi H, Chandra S, Markowitz J, Smalley I, Liu JKC, Chen YA, Najjar YG, Karreth FA, Abate-Daga D, Glitza IC, Sosman JA, Sondak VK, Bosenberg M, Herlyn M, Atkins MB, Kluger H, Margolin K, Forsyth PA, Davies MA, Smalley KSM.Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell Melanoma Res. 32:458, 2019

11. Karz A, Dimitrova M, Kleffman K, Alvarez-Breckenridge C, Atkins MB, Boire A, Bosenberg M, Brastianos P, Cahill DP, Chen Q, Ferguson S, Forsyth P, Glitza Oliva IC, Goldberg SB, Holmen SL, Knisely JPS, Merlino G, Nguyen DX, Pacold ME, Perez-Guijarro E, Smalley KSM, Tawbi HA, Wen PY, Davies MA, Kluger HM, Mehnert JM, Hernando E (2022). Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell Melanoma Res. 35:554, 2022

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...